Cargando…
Safety and Tolerability of an Intra-seasonal Initiation of the SQ-Standardised Grass Allergy Immunotherapy Tablet: A Non-interventional Observational Study Investigating the Feasibility During Routine Administration
BACKGROUND AND OBJECTIVE: For specific immunotherapy to pollen allergy, a pre-seasonal start of treatment is recommended by international guidelines. In a placebo-controlled clinical trial with adults, an intra-seasonal start of therapy with the SQ-standardised grass allergy immunotherapy tablet (AI...
Autores principales: | Schwab, Jan-Alexander, Wolf, Hendrik, Schnitker, Jörg, Wüstenberg, Eike |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3775157/ https://www.ncbi.nlm.nih.gov/pubmed/23943141 http://dx.doi.org/10.1007/s40261-013-0115-8 |
Ejemplares similares
-
Intra-Seasonal Initiation of the SQ-Standardised Grass Allergy Immunotherapy Tablet Routinely Applied by Allergy Specialists and General Practitioners with Experience in Treatment of Allergy: A Non-Interventional Observational Study
por: Schwab, Jan-Alexander, et al.
Publicado: (2018) -
Health-Related Quality of Life During Routine Treatment with the SQ-Standardised Grass Allergy Immunotherapy Tablet: A Non-Interventional Observational Study
por: Horn, Andreas, et al.
Publicado: (2016) -
Tolerability of the SQ-standardised grass sublingual immunotherapy tablet in patients treated with concomitant allergy immunotherapy: a non-interventional observational study
por: Reiber, Rainer, et al.
Publicado: (2016) -
Tolerability of an Immunologically Enhanced Subcutaneous Immunotherapy Preparation in Patients Treated with Concomitant Allergy Immunotherapy: A Non-Interventional Observational Study
por: Reiber, Rainer, et al.
Publicado: (2017) -
Economic evaluation of SQ-standardized grass allergy immunotherapy tablet (Grazax(®)) in children
por: Ronaldson, Sarah, et al.
Publicado: (2014)